Cipla to pick 14.6% stake in Chase Pharmaceuticals for $1.5m

Drug firm Cipla Ltd today said it will acquire 14.6 per cent stake in US-based Chase Pharmaceuticals Corporation Inc for USD 1.5 million.

The investment will be done through Cipla's wholly owned subsidiary Cipla (EU) Ltd, UK.

Cipla also said it will make an additional USD 4.5 million investment in Chase upon achievement of certain milestones.

"..Company has signed a definitive agreement to invest USD 1.5 million in Chase Pharmaceuticals Corporation Inc, US, to acquire 14.6 per cent stake in Chase on a fully diluted basis," Cipla said in a BSE filing.

Chase is an early stage drug development company, engaged in novel approaches to improve treatments for Alzheimer's disease.

EDITORIAL OF THE DAY

  • Nothing short of a uniform civil code will work in India

    When the Jamiat-Ulama-I-Hind (JUH), a powerful body of muslim clerics dedicated to address the aspirations of the community, turns to quote the religi

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Tushar Gandhi

A democracy must stand up for its people

We are the world’s most populous dem­ocracy, but behave in ...

Purnendu Ghosh

A curious and an innovative mind

Curiosity is hard-wired into our psyche. We all recognise that ...

Shona Adhikari

A good time for European art auctions

This week, we bring you interesting art news and the ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture